Rome, September 23, 2025 – The clinical study “Efficacy of a Dietary Supplement Containing Choline, Glutathione, Selenium, Zinc, L. rhamnosus, and B. lactis on Short-term Steatosis and Liver Function: A Pilot Study,” conducted by Drs. Massimo De Luca and Ciro Guerriero at the U.O.C. – AORN Cardarelli, has been published.
The clinical study demonstrated a reduction in the transaminases ALT, AST, and GGT—a clinically significant improvement in liver function—in patients with MASLD (metabolic dysfunction-associated steatotic liver disease) following 4 months of supplementation.
Improvements were also observed in other indicators related to hepatic steatosis, such as a reduction in CAP (Controlled Attenuation Parameter)—that is, the amount of fat accumulated in the liver—and an improvement in the metabolic profile, confirming the potential of EPATOril PRO® as a valuable aid in managing this condition.
The study was published in the scientific journal JScholar and is freely available at this link.
EPATOril PRO®: a scientifically formulated product for liver health
The data from the clinical study conducted by Drs. De Luca and Guerriero represent a concrete step toward nutraceutical innovation: scientifically validated solutions aimed at providing benefits and expert support for liver health.
Deltha Pharma: Research, Innovation, and a Culture of Well-Being
Deltha Pharma is an Italian company that, since 2009, has been dedicated to creating innovative dietary supplements, for which it has been repeatedly recognized as an Italian Excellence and Growth Leader.
Its goal is to provide people with effective, innovative, sustainable, and highest-quality supplements that support them throughout a happy and healthy life.
These supplements have a positive impact on the entire community, the local economy, and the environment. Among them, the MASUROTA® line of probiotics (patented in collaboration with the Gemelli Polyclinic/Catholic University of the Sacred Heart) and the DELTHAmannosio® urogynecological line stand out.
The quality of our work and products is attested by certifications such as HACCP, ISO 9001, ISO 14001, UNI/PdR 125:2022, and ISO 45001. Through these last two certifications in particular, Deltha Pharma places special emphasis on the importance of a safe, fair, inclusive workplace that values diversity.